1205 East Washington Street | Suite 111 | Louisville, KY | 40206

Onglyza Linked to Increased Heart Failure

Onglyza Linked to Increased Heart Failure

Jones Ward is investigating claims related to the diabetes drug Onglyza to cause heart failure or death. Onglyza is prescribed to treat symptoms of Type 2 Diabetes and is intended to lower glucose levels and other complications associated with Adult Type 2 diabetes.

Why is Onglyza Under Review?

According to the Food and Drug Administration, users of Onglyza may face an increased risk of congestive heart failure. The FDA is also considering an update to Onglyza’s label to warn against such heart failure that is not currently on the label. If you or someone you know takes Onglyza, you should talk with them about the drug. A 2013 study demonstrated that Onglyza users might face a 27% increase in rate of patient hospitalization for heart failure, compared to those taking a placebo.

What Happens Next?

If you or a loved one took the brand name drug Onglyza and suffered heart failure or death, please contact the defective drug and device attorneys at Jones Ward today. Jones Ward provides free case consultations and will be honest with you about your claim against the producer of the drug. To speak with an attorney at Jones Ward today, call (888) 595-2922 or click here to submit your contact information and a member of Jones Ward will quickly be in touch.